Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation a critically appraised topic

Neurologist

Volumn 15, Issue 1, 2009, Pages 44-48

  Almaraz, Amy C ^a   Bobrow, Bentley J ^b,c   Wingerchuk, Dean M ^a   Wellik, Kay E ^d   Demaerschalk, Bart M ^b  

^a Departments of Neurology   (United States)

^b MAYO CLINIC   (United States)

^c ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^d Division of Educations Services   (United States)

Author keywords

Cardiopulmonary resuscitation; Critically appraised topic; Diagnosis; Evidence based medicine; Nervous system specific enolase; Neuron specific enolase; Outcome; Phosphopyruvate hydratase; Prediction; Prognosis

Indexed keywords

ADRENALIN; NEURON SPECIFIC ENOLASE;

ANAMNESIS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMA; DIAGNOSTIC ACCURACY; ENZYME BLOOD LEVEL; HEALTH CARE PERSONNEL; HEART ARREST; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; SENSITIVITY AND SPECIFICITY; STROKE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOPULMONARY RESUSCITATION; COHORT STUDIES; COMA; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59449100829     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318191f810     Document Type: Article

References (26)

1. Dunne RB, Compton S, Zalenski RJ, et al. Outcomes from out-of-hospital cardiac arrest in Detroit. Resuscitation. 2007;72:59-65.
2. Eckstein M, Stratton SJ, Chan LS. Cardiac arrest resuscitation evaluation in Los Angeles: CARE-LA. Ann Emerg Med. 2005;45:504-509.
3. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest. JAMA. 2008;299:1158-1165.
4. Herlitz J, Ekstrom L, Wennerblom B, et al. Hospital mortality after out-of hospital cardiac arrest among patients found in ventricular fibrillation. Resuscitation. 1995;29:11-21.
5. Brain Resuscitation Clinical Trial II Study Group. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med. 1991;324:1225-1231.
6. Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10:269-295.
7. Riesinger J, Hollinger K, Wolfgang L, et al. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase. Eur Heart J. 2007;28:52-58.
8. Wijdicks EF, Hijdra A, Young GB, et al. For the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006; 67:203-210.
9. Cummins RO, Chamberlain DA, Abramson NS, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation. 1991;84:960-975.
10. Bernard SA, Gray TW, Buist MD, et al. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.
11. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Part 7.5: postresuscitation support. Circulation. 2005;112(suppl 24):IV-84-IV-88.
12. Tiainen M, Roine RO, Pettila V, et al. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke. 2003;34:2881-2886.
13. Meynaar IA, Oudemans-van Straaten HM, Wetering J, et al. Serum neuronspecific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med. 2003;29:189-195.
14. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;25:558-565.
15. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor Outcome within the first 3 days of postanoxic coma. Neurology. 2006;66:62-68.
16. Martens P. Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors. Acad Emerg Med. 1996;3:126-131.
17. Beaudeux JL, Leger P, Dequen L, et al. Influence of hemolysis on the measurement of S-100B protein and neuronspecific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem. 2000;46:989-990.
18. Rabinowicz A, Correale J, Boutros RB, et al. Neuron specific enolase is increased after single seizures during inpatient EEG/video monitoring. Epilepsia. 1996;37:122-125.
19. Willert C, Spitzer C, Kusserow S, et al. Serum neuron-specific enolase, prolactin, and creatine kinase after epileptic and psychogenic non-epileptic seizures. Acta Neurol Scand. 2004;109:318-323.
20. Wong M, Ess K, Landt M. Cerebrospinal fluid neuron-specific enolase following seizures in children: role of etiology. J Child Neurol. 2002;17:261-264.
21. Palmio J, Peltola J, Vuorinen P, et al. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. J Neurol Sci. 2001;183:27-31.
22. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006;67:637-643.
23. Body JJ, Paesmans M, Sculier JP, et al. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuronspecific enolase in patients with lung cancer. Clin Chem. 1992;38:748-751.
24. Schmitt UM, Stieber P, Hasholzner U, et al. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase. Eur J Clin Chem Clin Biochem. 1996;34:679-682.
25. Zandbergen EGJ, de Haan RJ, Stoutenbeek CP, et al. Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet. 1998; 352:1808-1812.
26. Chen R, Bolton C, Young G. Prediction of outcome in patients with anoxic coma: a clinical and electrophysiologic study. Crit Care Med. 1996;24:672-678.